Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...

In the past, Dr. Horowitz had been a paid consultant for Purple Biotech.

Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...

Acquisition to strengthen key pillar of BioNTech’s oncology strategy aimed at establishing BNT327 as a pan-tumor technology platformfor the ...

Acquisition to strengthen key pillar of BioNTech's oncology strategy aimed at establishing BNT327 as a pan-tumor technology platform for the treatment of advanced cancersWith the closing of the transa ...

Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

Vaccines do not cause autism. You’ve almost certainly read that before — but often without a full explanation of how we know ...

FY25 saw AdAlta focus on increasing its corporate muscle, with two new board members and additional advisors engaged. ...

Imsidolimab has successfully completed two global Phase 3 studies in Generalized Pustular Psoriasis <li /> Vanda expects to immediately ...

The Feinstein Institutes for Medical Research and the journal Bioelectronic Medicine announced that Michael Kilgard, PhD, Robert Rennaker, PhD, and Seth Hays, PhD, distinguished researchers and ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced ...